News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
762,598 Results
Type
Article (54349)
Company Profile (460)
Press Release (707788)
Multimedia
Podcasts (104)
Webinars (16)
Section
Business (217139)
Career Advice (2862)
Deals (37294)
Drug Delivery (121)
Drug Development (86945)
Employer Resources (184)
FDA (17221)
Job Trends (15944)
News (368783)
Policy (35639)
Tag
Academia (2921)
Academic (1)
Accelerated approval (11)
Adcomms (30)
Allergies (105)
Alliances (53303)
ALS (119)
Alzheimer's disease (1552)
Antibody-drug conjugate (ADC) (180)
Approvals (17179)
Artificial intelligence (346)
Autoimmune disease (34)
Automation (18)
Bankruptcy (391)
Best Places to Work (12287)
BIOSECURE Act (20)
Biosimilars (131)
Biotechnology (347)
Bladder cancer (100)
Brain cancer (38)
Breast cancer (387)
Cancer (3035)
Cardiovascular disease (240)
Career advice (2402)
Career pathing (33)
CAR-T (201)
CDC (38)
Cell therapy (540)
Cervical cancer (23)
Clinical research (71183)
Collaboration (1092)
Company closure (3)
Compensation (699)
Complete response letters (31)
COVID-19 (2848)
CRISPR (67)
C-suite (351)
Cystic fibrosis (119)
Data (3066)
Decentralized trials (2)
Denatured (33)
Depression (75)
Diabetes (368)
Diagnostics (6782)
Digital health (24)
Diversity (10)
Diversity, equity & inclusion (46)
Drug discovery (151)
Drug pricing (145)
Drug shortages (31)
Duchenne muscular dystrophy (132)
Earnings (90140)
Editorial (47)
Employer branding (23)
Employer resources (159)
Events (122107)
Executive appointments (904)
FDA (18918)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (987)
Gene editing (144)
Generative AI (27)
Gene therapy (422)
GLP-1 (893)
Government (4985)
Grass and pollen (6)
Guidances (181)
Healthcare (20217)
HIV (43)
Huntington's disease (32)
IgA nephropathy (44)
Immunology and inflammation (178)
Immuno-oncology (10)
Indications (40)
Infectious disease (3037)
Inflammatory bowel disease (162)
Inflation Reduction Act (13)
Influenza (69)
Intellectual property (123)
Interviews (555)
IPO (17195)
IRA (53)
Job creations (4086)
Job search strategy (1977)
Kidney cancer (15)
Labor market (52)
Layoffs (562)
Leadership (25)
Legal (8756)
Liver cancer (85)
Longevity (12)
Lung cancer (428)
Lymphoma (213)
Machine learning (11)
Management (62)
Manufacturing (411)
MASH (98)
Medical device (14155)
Medtech (14160)
Mergers & acquisitions (20812)
Metabolic disorders (931)
Multiple sclerosis (103)
NASH (23)
Neurodegenerative disease (137)
Neuropsychiatric disorders (41)
Neuroscience (2293)
NextGen: Class of 2025 (7247)
Non-profit (4905)
Now hiring (47)
Obesity (475)
Opinion (273)
Ovarian cancer (104)
Pain (117)
Pancreatic cancer (124)
Parkinson's disease (198)
Partnered (22)
Patents (312)
Patient recruitment (169)
Peanut (55)
People (62747)
Pharmaceutical (88)
Pharmacy benefit managers (23)
Phase I (22194)
Phase II (31245)
Phase III (23269)
Pipeline (1677)
Policy (231)
Postmarket research (2932)
Preclinical (9588)
Press Release (70)
Prostate cancer (149)
Psychedelics (45)
Radiopharmaceuticals (274)
Rare diseases (511)
Real estate (6434)
Recruiting (73)
Regulatory (24586)
Reports (51)
Research institute (2589)
Resumes & cover letters (454)
Rett syndrome (10)
RNA editing (10)
RSV (54)
Schizophrenia (97)
Series A (169)
Series B (117)
Service/supplier (13)
Sickle cell disease (67)
Special edition (21)
Spinal muscular atrophy (160)
Sponsored (35)
Startups (3923)
State (2)
Stomach cancer (17)
Supply chain (81)
Tariffs (63)
The Weekly (69)
Vaccines (875)
Venture capital (57)
Weight loss (309)
Women's health (50)
Worklife (19)
Date
Today (79)
Last 7 days (401)
Last 30 days (1979)
Last 365 days (32742)
2025 (17602)
2024 (37097)
2023 (41881)
2022 (53201)
2021 (57863)
2020 (56595)
2019 (49831)
2018 (37686)
2017 (34693)
2016 (34520)
2015 (40611)
2014 (34649)
2013 (29961)
2012 (31987)
2011 (32484)
2010 (30722)
Location
Africa (917)
Alabama (69)
Alaska (7)
Arizona (260)
Arkansas (14)
Asia (43170)
Australia (7805)
California (7668)
Canada (2405)
China (711)
Colorado (330)
Connecticut (336)
Delaware (198)
Europe (96593)
Florida (1132)
Georgia (253)
Hawaii (1)
Idaho (63)
Illinois (687)
India (28)
Indiana (371)
Iowa (18)
Japan (234)
Kansas (112)
Kentucky (32)
Louisiana (15)
Maine (64)
Maryland (1073)
Massachusetts (5788)
Michigan (255)
Minnesota (471)
Mississippi (3)
Missouri (98)
Montana (31)
Nebraska (25)
Nevada (80)
New Hampshire (72)
New Jersey (2135)
New Mexico (31)
New York (2149)
North Carolina (1194)
North Dakota (9)
Northern California (3339)
Ohio (240)
Oklahoma (16)
Oregon (39)
Pennsylvania (1644)
Puerto Rico (18)
Rhode Island (39)
South America (1294)
South Carolina (35)
South Dakota (1)
Southern California (2855)
Tennessee (129)
Texas (1155)
United States (28647)
Utah (226)
Virginia (195)
Washington D.C. (78)
Washington State (664)
West Virginia (4)
Wisconsin (72)
762,598 Results for "tenax therapeutics formerly known as oxygen biotherapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tenax Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
May 15, 2025
·
7 min read
Press Releases
Tenax Therapeutics Announces $25 Million Private Placement
March 5, 2025
·
3 min read
Press Releases
Tenax Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
April 1, 2025
·
1 min read
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Bio NC
Tenax Therapeutics to Present at the 36th Annual Roth Conference
Tenax Therapeutics, Inc. today announced that it will participate in the 36th Annual Roth Conference in Dana Point, California, from March 17-19, 2024.
March 12, 2024
·
1 min read
Press Releases
Tenax Therapeutics to Participate in the Leerink Partners 2025 Global Healthcare Conference
March 3, 2025
·
1 min read
Press Releases
Tenax Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
March 25, 2025
·
8 min read
Press Releases
Tenax Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference
January 31, 2025
·
3 min read
Business
Tenax Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
Tenax Therapeutics, Inc. (Nasdaq: TENX), a Phase 3, development-stage pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, announced financial results for the first quarter of 2024 and provided a corporate update.
May 14, 2024
·
11 min read
Bio NC
Tenax Therapeutics Announces Oral Presentation of Levosimendan for the Treatment of PH-HFpEF at THT 2024
Tenax Therapeutics, Inc. today announced Dr. Sanjiv Shah will present data and review the scientific basis for the use of levosimendan in PH-HFpEF.
February 29, 2024
·
5 min read
1 of 76,260
Next
